Financing, Equity Capital Markets

CymaBay Therapeutics, Inc.

09/23
|
$258.7 Million
Cymabay
Piper Sandler served as bookrunner for CymaBay Therapeutics, Inc. on a follow-on offering
Sub-Type
Follow-On Offering
Sub-Sector
Biopharma